Cargando…
Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes
Diabetic cardiomyopathy (DCM) is characterized by diastolic relaxation abnormalities in its initial stages and by clinical heart failure (HF) without dyslipidemia, hypertension, and coronary artery disease in its last stages. DCM contributes to the high mortality and morbidity rates observed in diab...
Autores principales: | Deng, Jianxin, Liao, Yunxiu, Liu, Jianpin, Liu, Wenjuan, Yan, Dewen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740193/ https://www.ncbi.nlm.nih.gov/pubmed/35004678 http://dx.doi.org/10.3389/fcell.2021.777258 |
Ejemplares similares
-
Changes in N6-Methyladenosine Modification Modulate Diabetic Cardiomyopathy by Reducing Myocardial Fibrosis and Myocyte Hypertrophy
por: Ju, Wenhao, et al.
Publicado: (2021) -
Mitophagy in Diabetic Cardiomyopathy: Roles and Mechanisms
por: Zheng, Haoxiao, et al.
Publicado: (2021) -
Combined Administration of Metformin and Atorvastatin Attenuates Diabetic Cardiomyopathy by Inhibiting Inflammation, Apoptosis, and Oxidative Stress in Type 2 Diabetic Mice
por: Jia, Weikun, et al.
Publicado: (2021) -
Hydrogen Sulfide Plays an Important Role in Diabetic Cardiomyopathy
por: Zhao, Shizhen, et al.
Publicado: (2021) -
Mst1 Knockout Alleviates Mitochondrial Fission and Mitigates Left Ventricular Remodeling in the Development of Diabetic Cardiomyopathy
por: Feng, Xinyu, et al.
Publicado: (2021)